Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Reprogramming tumour cells using an antimalarial drug

Research

Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.

Hidden lung damage from COVID-19 revealed in new study

Research Translational Research

Early findings from a study into longer-term damage amongst patients recovering from COVID-19 suggest that the use of cutting-edge scanning techniques may detect previously unseen lung damage.

Professor Sibson secures further MRC DPFS funding

Awards & Appointments Clinical Trials Translational Research

Prof. Sibson together with her co-applicants Prof. Anthony, Dr Campbell and Prof. Middleton have now been awarded a second MRC DPFS grant, for £3.3 million, to acquire further preclinical data to support the case for clinical translation, to develop the mutTNF production for human use and to undertake pre-clinical toxicology.

Oxfordshire-based SCAN pathway wins BMJ award

Innovation Research

A pathway designed to investigate individuals with non-specific but concerning symptoms of cancer wins the BMJ Awards 2020 Cancer Care Team of the Year.

Tackling the serious side effects of cancer treatment in an ageing population

Publication Research

Prof. Anne Kiltie and her team discuss their important work into the effects of radiosensitisation on ageing cancer patients with the CRUK Science Blog.

Vice-Chancellor's Innovation Awards 2020

Awards & Appointments Department

Congratulations to Professor Anna Schuh and her team who are the Winners of the Teamwork category in the Vice-Chancellor Innovation Awards 2020 for their work on SEREN_A Social Enterprise to deliver DNA-based diagnostics that improves outcomes of children and young adults with blood diseases in sub-Saharan Africa.

New digital classification method using AI developed for colorectal cancer

Artificial Intelligence Research Translational Research

Understanding the molecular subtype of a cancer is becoming an importance part of the diagnostic process as it helps a doctor better understand a patient’s prognosis, determine the best course of action for treatment and helps researchers devise new, more-efficient, precision therapies.

The CNIO creates a collaborative platform to streamline brain metastasis research

Research

Professor Nicola Sibson has been involved in the CNIO platform to compile a repository for brain metastasis cell lines.

Oxford University to lead a new national programme of AI research to improve lung cancer screening

Artificial Intelligence Funding

UK Research and Innovation, Cancer Research UK and industry are investing more than £11 million in an Oxford-led artificial intelligence (AI) research programme to improve the diagnosis of lung cancer and other thoracic diseases.

Vice-Chancellor's Education Awards 2020

Awards & Appointments Department Teaching

We are delighted to announce that three members of the Department of Oncology have been part of a project team which has been awarded a Vice-Chancellor's Education Award for 2020.

Virtual teaching with AimHi

General Outreach Research

One of our scientists, Dr Hannah Bolland, has become a virtual teacher, connecting school students with science.

New Fellow of the Society for Radiological Protection

Awards & Appointments Research

Many congratulations to Dr Mark Hill, who has become a Fellow of the Society for Radiological Protection (FSRP).

Integrating Cancer Imaging Biomarker Clinical Research Across the UK

Research

UK National Cancer Imaging Translational Accelerator (NCITA) establishes infrastructure for validation and adoption of cancer imaging biomarkers as decision-making tools in clinical trials and NHS practice. Researchers and medical experts from nine world-leading medical imaging centres across the UK come together to form an integrated infrastructure for standardising and validating cancer imaging biomarkers for clinical use.

Ramandan Group publish original scientific article in Nature Communications

Publication Research

Group of Professor Kristijan Ramadan has published an original scientific article in Nature Communications today. The article has the first report of a new autophagy receptor TEX264, which may be involved in tumours developing drug resistance.

Lifetime Achievement Award for Prof Talbot

Awards & Appointments Department

Congratulations to Professor Denis Talbot who has been awarded the Lifetime Achievement Award from the British Thoracic Oncology Group (BTOG).

Careers Fair

Department Outreach

On 13 February, OCTO Trial Manager Lucy Griffiths staffed a stand about Clinical Trials at a tri-school Careers Fair in West London.

Science and Safety

Department Public Engagement

On 3 February, we hosted a visiting group of students from Buckinghamshire College.

Teaching in the Oxford Department of Education

Department

Friday 14 February was the day of our annual visit to Oxford's Department of Education to spend some time with their trainee teachers.

Load More